Mayo Clinic Laboratories, Helix collaborate to provide suite of laboratory services to biopharma customers
January 10, 2023 -- Mayo Clinic Laboratories and Helix on Tuesday announced a strategic collaboration that will provide biopharma customers access to a comprehensive joint laboratory offering for research and development initiatives across the drug development lifecycle. Read More
Berkeley Lights launches optofluidic system
January 10, 2023 -- Berkeley Lights, Inc., a life sciences tools company, announced the launch of the Beacon Select, its two-chip, single-cell optofluidic system for cell line development (CLD). Read More
Protillion Biosciences raises $18M in financing to support therapeutic biomarker discovery
December 19, 2022 -- Protillion Biosciences, a privately held biotech company launched in 2019 to identify and optimize new protein therapeutics, on Monday announced the completion of an $18 million Series A financing from Arch Venture Partners and Illumina Ventures. Read More
MinervaX announces funding for Group B Streptococcus vaccine
December 15, 2022 -- Danish biotechnology company MinervaX ApS announced the completion of a 72-million-euro ($76.3 million) financing round to advance development of a novel vaccine against Group B Streptococcus (GBS). An equity financing of 22 million euros was co-led by new investors Trill Impact Ventures and Pureos Bioventures and existing investors. The European Investment Bank provided additional funding in a form of a 50-million-euro loan. Read More
Vegetables contain ‘garden variety’ cancer drugs
December 8, 2022 -- Polish scientists have revealed the potential for new cancer drugs formulated from nightshade plants (genus Solanum), including potatoes and eggplants. Read More
Rice University lab receives $3M grant to develop HIV treatment
December 6, 2022 -- Researchers from Rice University have been awarded a $3 million grant from the Bill & Melinda Gates Foundation to develop a once-a-year treatment for HIV and other infectious diseases. Read More
Researchers discover ‘QR code’ of GPCR protein couplings
December 6, 2022 -- Scientists from cancer research and treatment center City of Hope have identified how the G protein-coupled receptor (GPCR) works, which could further investigations of how the protein’s coupling with other proteins can impact how cells respond to medicines with fewer side effects. Read More
Opioids could be made safer by targeting sodium pockets: study
December 5, 2022 -- Chemically linking fentanyl to the sodium pockets that exist within nerve cell receptors could block the drug's harmful side effects and still reduce pain, according to a new study. Read More
New approach facilitates natural products drug discovery
December 2, 2022 -- A new approach to natural products drug discovery integrates information from molecular biology, analytical chemistry, and bioinformatics to help address the current challenges of screening these products to identify potential drugs. Read More
New AI-based framework holds promise for drug discovery
December 1, 2022 -- Using the artificial intelligence (AI) method of convolutional neural networks, researchers in China developed a new framework for finding novel drug candidates. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
